GL1X · GenesisL1 explorer

MolNFT v1 · #50915 · protein

X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing agents, thiocyanate, methylparaben and phenol

2TCI · Thiocyanate insulin: “X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing agents…”. X-ray diffraction, 2 ligands (ZN, SCN). MolNFT v1 #50915 on GenesisL1: 3D structure, binding sites and pockets…

PDB
2TCI
Type
protein
Length
100 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thiocyanate insulin
UniProt
P01315
Ligands
ZN, SCN

Structure

x-ray diffraction · 3 distinct chains · 59% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CThiocyanate insulinprotein2162% helix, 5% strandP01315
BThiocyanate insulinprotein2868% helix, 11% strandP01315
DThiocyanate insulinprotein3050% helix, 10% strandP01315

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains B, D
  • SCN · Thiocyanate ion · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

5 interfaces between chains.

  • C–D · 805 Ų buried · 12 hydrogen bonds · protein-protein
  • B–D · 662 Ų buried · 12 hydrogen bonds · protein-protein
  • A–B · 585 Ų buried · 3 hydrogen bonds · protein-protein
  • B–C · 62 Ų buried · 0 hydrogen bonds · protein-protein
  • A–D · 36 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 2TCI · X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.